Patents by Inventor Sergio Cantoreggi

Sergio Cantoreggi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180256567
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: March 16, 2018
    Publication date: September 13, 2018
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Patent number: 9943515
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: April 17, 2018
    Assignee: Helsinn Healthcare SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Patent number: 9358228
    Abstract: Combinations of netupitant and palonosetron, and methods of using such combinations to treat various pain states and irritable bowel syndrome, are provided.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: June 7, 2016
    Assignee: HELSINN HEALTHCARE SA
    Inventors: Claudio Pietra, Sergio Cantoreggi
  • Publication number: 20160136162
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: January 21, 2016
    Publication date: May 19, 2016
    Applicant: Helsinn Healthcare SA
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Patent number: 9271975
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: March 1, 2016
    Assignee: HELSINN HEALTHCARE SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Patent number: 9186357
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: November 17, 2015
    Assignee: HELSINN HEALTHCARE SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Patent number: 8951969
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: February 10, 2015
    Assignee: Helsinn Healthcare SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Publication number: 20140256737
    Abstract: Combinations of netupitant and palonosetron, and methods of using such combinations to treat various pain states and irritable bowel syndrome, are provided.
    Type: Application
    Filed: October 10, 2012
    Publication date: September 11, 2014
    Applicant: Helsinn Healthcare SA
    Inventors: Claudio Pietra, Sergio Cantoreggi
  • Publication number: 20140194438
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: November 1, 2013
    Publication date: July 10, 2014
    Applicant: Helsinn Healthcare S.A.
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Publication number: 20140194395
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: November 1, 2013
    Publication date: July 10, 2014
    Applicant: Helsinn Healthcare S.A.
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Publication number: 20140193487
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: November 1, 2013
    Publication date: July 10, 2014
    Applicant: Helsinn Healthcare S.A.
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Patent number: 8623826
    Abstract: Provided are methods for treating nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery, comprising the co-administration of netupitant, palonosetron and dexamethasone.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: January 7, 2014
    Assignee: Helsinn Healthcare S.A.
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Publication number: 20120064153
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: March 31, 2011
    Publication date: March 15, 2012
    Applicant: HELSINN HEALTHCARE SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo, Riccardo Braglia
  • Publication number: 20110178118
    Abstract: Methods and compositions for reducing chemotherapy and radiotherapy induced emises with 5-HT3 receptor antagonists are disclosed, especially with palonosetron.
    Type: Application
    Filed: March 31, 2011
    Publication date: July 21, 2011
    Inventors: Alberto Macciocchi, Sergio Cantoreggi, Enrico Braglia, Riccardo Branglia, Simone Macciocchi, Giulio Macciocchi
  • Publication number: 20100261734
    Abstract: The present invention relates to methods for reducing the frequency of bladder contractions without significantly affecting micturition pressure, comprising administering a pharmaceutical composition comprising a therapeutically effective amount of netupitant, or a pharmaceutically acceptable salt or prodrug thereof. The method can be used to treat bladder dysfunction without significantly increasing residual volume, including urgency, frequency, pollakiuria, nocturia, low deferment time, suboptimal volume threshold, neurogenic bladder, or combinations thereof.
    Type: Application
    Filed: April 12, 2010
    Publication date: October 14, 2010
    Applicant: Helsinn Healthcare S.A.
    Inventors: Claudio Pietra, Sergio Cantoreggi, Riccardo Braglia
  • Publication number: 20060079545
    Abstract: Methods and compositions for reducing chemotherapy and radiotherapy induced emises with 5-HT3 receptor antagonists are disclosed, especially with palonosetron.
    Type: Application
    Filed: May 16, 2005
    Publication date: April 13, 2006
    Applicant: Helsinn Healthcare SA
    Inventors: Alberto Macciocchi, Sergio Cantoreggi, Enrico Braglia, Riccardo Braglia, Simone Macciocchi, Giulio Macciocchi
  • Patent number: D665072
    Type: Grant
    Filed: September 8, 2011
    Date of Patent: August 7, 2012
    Assignee: Helsinn Healthcare S.A.
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo, Riccardo Braglia